Latest filing published 19 Dec 2025 for Savara Inc, €103k. Read the official filing
Across 25 buy signals with a settled T+90 return. Return basis: close on the day after publication.
David A. Ramsay (board member) discloses dealings in 2 companies, chiefly Savara Inc and La Jolla Pharmaceutical Co. Over a trading history stretching from 18 May 2021 to 19 December 2025, the count stands at 33 filings.
Market trades split into 28 purchases (€1.4M) and 1 sale (€103k). On balance, insiders were net buyers of €1.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 3 share grants. Since January 2025: 1 purchase and 1 sale on the market.
The median purchase comes to €19k. Clusters matter here: 12 out of 28 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.
Most recently, on 19 December 2025, the filings show an open-market sale worth €103k in Savara Inc. The last purchase on record was published on 1 April 2025, which is 565 days ago. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 33 declarations